Back to Aberdeen Group plc

ABT
Showing 8 of 29 quarters

Position history for Aberdeen Group plc's holdings in ABBOTT LABORATORIES

Aberdeen Group plc holds 2M shares of ABT (ABBOTT LABORATORIES), worth $209.8M as of 2026-Q1. The position was increased (+2.5% shares). ABT represents 0.3% of Aberdeen Group plc's portfolio.

Current Value

$209.8M

Current Shares

2M

Total Value Change

+$86.6M

Total Shares Change

+858,228

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2M
+2.5%
$209.8M0.3%$113.61
37
2025-Q4
Increased
2M
+1.2%
$249.8M0.4%$125.15
37
2025-Q3
Decreased
2M
-2.4%
$262.1M0.4%$131.85
0
2025-Q2
Increased
2M
+4.2%
$272.9M0.5%$132.52
38
2025-Q1
Increased
1.9M
+51.9%
$256M0.5%$128.41
51
2024-Q4
Increased
1.3M
+3.0%
$143.8M0.3%$110.14
37
2024-Q3
Increased
1.2M
+4.5%
$139.2M0.3%$109.27
38
2024-Q2
Decreased
1.2M
-1.9%
$123.2M0.2%$100.45
0

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used